Dan Shen

2.7k total citations
85 papers, 1.8k citations indexed

About

Dan Shen is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Dan Shen has authored 85 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 15 papers in Immunology and 15 papers in Cancer Research. Recurrent topics in Dan Shen's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Tuberculosis Research and Epidemiology (5 papers). Dan Shen is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Tuberculosis Research and Epidemiology (5 papers). Dan Shen collaborates with scholars based in China, United States and Australia. Dan Shen's co-authors include Zeyi Liu, Yuanyuan Zeng, Jianjie Zhu, Nan Zhang, Wenwen Du, Jianan Huang, Jian‐An Huang, Zhe Lei, Hualong Qin and Xu‐Fang Liang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and PEDIATRICS.

In The Last Decade

Dan Shen

79 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Shen China 23 710 381 353 318 208 85 1.8k
Weihua Yuan China 22 1.0k 1.4× 363 1.0× 172 0.5× 185 0.6× 236 1.1× 48 2.4k
Peng Zhao China 21 703 1.0× 498 1.3× 180 0.5× 179 0.6× 182 0.9× 84 1.5k
Xiayu Rao United States 16 947 1.3× 309 0.8× 174 0.5× 312 1.0× 152 0.7× 23 2.0k
Rongquan Wang China 26 925 1.3× 396 1.0× 390 1.1× 363 1.1× 113 0.5× 91 1.8k
Zuzana Dobbie Switzerland 18 927 1.3× 410 1.1× 182 0.5× 237 0.7× 99 0.5× 30 2.2k
Liyun Zhang China 26 911 1.3× 177 0.5× 485 1.4× 235 0.7× 178 0.9× 119 2.2k
Xiaoyan Du China 23 673 0.9× 257 0.7× 347 1.0× 189 0.6× 126 0.6× 103 1.8k
Anna Negroni Italy 27 992 1.4× 236 0.6× 463 1.3× 240 0.8× 111 0.5× 56 1.9k
Kaoru Hazeki Japan 25 1.3k 1.8× 267 0.7× 1.2k 3.3× 265 0.8× 95 0.5× 64 2.8k

Countries citing papers authored by Dan Shen

Since Specialization
Citations

This map shows the geographic impact of Dan Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Shen more than expected).

Fields of papers citing papers by Dan Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Shen. The network helps show where Dan Shen may publish in the future.

Co-authorship network of co-authors of Dan Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Shen. A scholar is included among the top collaborators of Dan Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Shen. Dan Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Xinyu, Pengfei Mao, Minghui Wang, et al.. (2025). A biomimetic liposome platform targeting non-small cell lung cancer to modulate the inflammatory and metabolic microenvironment for enhanced therapy. Chemical Engineering Journal. 515. 163555–163555.
2.
Cai, Aimin, Dan Shen, Jie Ding, et al.. (2025). α-methyltryptophan-mediated protection against diabetic nephropathy in db/db mice as studied with a metabolomics approach. Frontiers in Pharmacology. 15. 1463673–1463673. 1 indexed citations
3.
Chen, Cheng, et al.. (2025). Isoliensinine exerts antitumor effects in lung adenocarcinoma by inhibiting APEX1-driven ROS production. Frontiers in Pharmacology. 16. 1555802–1555802. 1 indexed citations
5.
Huang, Huirong, Shengjie Li, Yuqi Yan, et al.. (2024). Chondrocyte-targeted bilirubin/rapamycin carrier-free nanoparticles alleviate oxidative stress and modulate autophagy for osteoarthritis therapy. Journal of Controlled Release. 378. 517–533. 13 indexed citations
6.
Iqbal, Javed, et al.. (2023). MicroRNA expression profiles of stress susceptibility and resilience in the prelimbic and infralimbic cortex of rats after single prolonged stress. Frontiers in Psychiatry. 14. 1247714–1247714. 2 indexed citations
7.
Zhang, Xiaoxue, Tong Ge, Dan Shen, et al.. (2023). Core–shell structure of carbon nanohorns and pH-sensitive liposome for doxorubicin and tumor-associated macrophage polarization factor interleukin-21 codelivery. Journal of Drug Delivery Science and Technology. 86. 104743–104743. 1 indexed citations
8.
Shen, Dan, et al.. (2023). The characteristics of excitatory lineage differentiation and the developmental conservation in Reeler neocortex. Cell Proliferation. 57(5). e13587–e13587. 1 indexed citations
9.
Chen, Yun, Chenyun Miao, Ying Zhao, et al.. (2023). Inflammasomes in human reproductive diseases. Molecular Human Reproduction. 29(10). 17 indexed citations
10.
Huang, Shihao, Fanglin Liu, Yue Si, et al.. (2023). Activation of Epac in the BLA disrupts reconsolidation and attenuates heroin‐seeking behaviour. Addiction Biology. 28(10). e13330–e13330. 3 indexed citations
11.
Shen, Dan, et al.. (2022). Research Progress on Functional Active Components and Its Efficacy in Rice Bran. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Shen, Dan, Yingjian Lu, Shuhua Tian, et al.. (2021). Effects of L‐arabinose by hypoglycemic and modulating gut microbiome in a high‐fat diet‐ and streptozotocin‐induced mouse model of type 2 diabetes mellitus. Journal of Food Biochemistry. 45(12). e13991–e13991. 21 indexed citations
13.
Tong, Lin, et al.. (2020). Airborne Bacteria Enriched PM2.5 Enhances the Inflammation in an Allergic Adolescent Mouse Model Induced by Ovalbumin. Inflammation. 43(1). 32–43. 11 indexed citations
14.
Zeng, Yuanyuan, Jianjie Zhu, Hualong Qin, et al.. (2017). Methylated +322–327 CpG site decreases hOGG1 mRNA expression in non-small cell lung cancer. Oncology Reports. 38(1). 529–537. 3 indexed citations
15.
Shen, Dan, Hao Li, Rui Zhou, et al.. (2017). Pioglitazone attenuates aging-related disorders in aged apolipoprotein E deficient mice. Experimental Gerontology. 102. 101–108. 31 indexed citations
16.
Zhang, Nan, Yuanyuan Zeng, Wenwen Du, et al.. (2016). The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer. International Journal of Oncology. 49(4). 1360–1368. 263 indexed citations
17.
Zhu, Jianjie, Yuanyuan Zeng, C. F. Xu, et al.. (2015). Expression profile analysis of microRNAs and downregulated miR-486-5p and miR-30a-5p in non-small cell lung cancer. Oncology Reports. 34(4). 1779–1786. 50 indexed citations
18.
Shen, Dan. (2014). Study on the effects of Compound Shougong Powder on the JAK2-STAT signaling pathway of mice with Lewis lung carcinoma. 2 indexed citations
19.
Liu, Fang, Anxia Jiao, Xirong Wu, et al.. (2014). Impact of Glutathione S-Transferase M1 and T1 on Anti-Tuberculosis Drug–Induced Hepatotoxicity in Chinese Pediatric Patients. PLoS ONE. 9(12). e115410–e115410. 15 indexed citations
20.
Shen, Chen‐Yang, Weiwei Jiao, Weixing Feng, et al.. (2013). IFNG polymorphisms are associated with tuberculosis in Han Chinese pediatric female population. Molecular Biology Reports. 40(9). 5477–5482. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026